US Broker Ratings

Crinetics Pharmaceuticals (CRNX) Stock Analysis: An Ambitious Biotech with a 92.58% Upside Potential

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a San Diego-based biotechnology company, has garnered significant attention in the investment community, thanks to its innovative approach to treating rare endocrine diseases and the..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Uncovering a 53.71% Potential Upside in Biotech

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stands as a fascinating player in the biotechnology sector, with a market capitalization of $3.08 billion. Based in Waltham, Massachusetts, Apellis is carving its niche..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Is a 50% Upside on the Horizon?

For investors with an eye on the healthcare sector, LifeStance Health Group, Inc. (NASDAQ: LFST) presents a compelling opportunity, particularly given its significant potential upside of over 50% according to..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Exploring a Potential 185.92% Upside for Biotech Investors

Viking Therapeutics, Inc. (NASDAQ: VKTX) stands out in the biotechnology sector with a market cap of $3.63 billion. Headquartered in the United States, the company is making waves with its..

Immunovant, Inc. (IMVT) Stock Analysis: Examining the 141% Potential Upside in Biotech Innovation

For investors with an appetite for risk and a keen interest in the biotechnology sector, Immunovant, Inc. (NASDAQ: IMVT) presents a compelling case with its significant upside potential. The company,..

Concentra Group Holdings Parent (CON) Stock Analysis: Strong Buy Ratings and 36% Potential Upside

Concentra Group Holdings Parent, Inc. (CON), a notable player in the healthcare sector, particularly within the medical care facilities industry, is drawing attention from individual investors. The company’s current market..

Sotera Health Company (SHC) Investor Outlook: Analyzing the Stock’s Resilience Amid Healthcare Sector Dynamics

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector’s diagnostics and research industry, offering a robust array of services that include sterilization, lab testing, and advisory solutions. With..

Perrigo Company plc (PRGO) Stock Analysis: Evaluating the 55% Upside Potential

As investors navigate the ever-evolving landscape of healthcare stocks, Perrigo Company plc (NYSE: PRGO) emerges as a notable consideration. Operating within the Drug Manufacturers – Specialty & Generic industry, this..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Insights Into Its 11.91% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is a notable player in the healthcare sector, specifically within the biotechnology industry, with its headquarters in Pittsburgh, Pennsylvania. As a commercial-stage biotechnology company, Krystal..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Significant Growth Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) is drawing considerable attention in the biotechnology sector, with its market cap reaching an impressive $5.82 billion. This commercial-stage biopharmaceutical company, headquartered in Morrisville, North..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a 48.56% Potential Downside Amidst Strong Revenue Growth

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology sector, has been attracting attention from investors due to its robust revenue growth and a stark contrast in..

Charles River Laboratories (CRL) Stock Analysis: Navigating Market Dynamics with Strategic Collaborations

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a pivotal player in the healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of $8.73 billion,..

HealthEquity, Inc. (HQY): Investor Outlook Reveals 37.87% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY) stands out in the healthcare sector, offering a unique blend of technology-enabled services that cater to both consumers and employers in the United States. With a..

iRhythm Technologies, Inc. (IRTC) Investor Outlook: A Growth-Driven Medical Device Innovator with a 5.92% Upside Potential

iRhythm Technologies, Inc. (NASDAQ: IRTC) is a digital healthcare company at the forefront of the medical device industry, specializing in ambulatory cardiac monitoring services. With its innovative Zio suite of..

Akero Therapeutics, Inc. (AKRO) Investor Outlook: Exploring a 67.68% Upside Potential

Akero Therapeutics, Inc. (NASDAQ: AKRO) has captured the attention of investors, particularly those with an eye on the biotechnology sector. With a robust market capitalization of $3.69 billion, Akero is..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Healthcare Leader with 22.96% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands out in the healthcare sector as a key player within the medical instruments and supplies industry. With a market capitalization of $4.99 billion,..

Sarepta Therapeutics, Inc. (SRPT)

⚠️ No article content returned.

..

Regencell Bioscience Holdings (RGC) Stock Analysis: Examining the Prospects of a TCM Innovator in Healthcare

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands at the intersection of traditional medicine and modern healthcare, offering investors a unique proposition in the pharmaceutical landscape. As a Hong Kong-based company..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: A Biotech Giant with 19.53% Potential Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a trailblazer in the biotechnology sector, is attracting significant attention from investors with its promising potential upside of 19.53%. With a market capitalization of $6.58..

The Ensign Group, Inc. (ENSG) Stock Analysis: Navigating a 18.5% Revenue Growth in Healthcare

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, is capturing investor attention with its impressive 18.5% revenue growth. As a company operating within the medical..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds